Evaluation of a multiparametric immunofluorescence assay for standardization of neuromyelitis optica serology (Q28728565)

Petra Nytrova

6

0 references

Antonio Bertolotto

Antonio Bertolotto

10

0 references

Agata Katia Patanella

5

Agata Katia Patanella

0 references

Patrizia Sola

7

Patrizia Sola

0 references

author name string

Letizia Granieri

1

0 references

Fabiana Marnetto

2

0 references

Paola Valentino

3

0 references

Jessica Frau

4

0 references

Marco Capobianco

Creative Commons Attribution 4.0 International

8

0 references

language of work or name

English

0 references

publication date

2012

0 references

published in

PLOS One

0 references

volume

7

0 references

issue

6

0 references

page(s)

e38896

0 references

copyright license

start time

12 June 2012

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3373605

Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

17 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3373605

IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel

17 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3373605

The Measurement of Observer Agreement for Categorical Data

17 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3373605

A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis

17 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3373605

Serologic diagnosis of NMO: a multicenter comparison of aquaporin-4-IgG assays.

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3373605

Antibodies to CV2/CRMP5 in neuromyelitis optica-like disease: case report and review of the literature

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3373605

Azathioprine: tolerability, efficacy, and predictors of benefit in neuromyelitis optica

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3373605

Neuromyelitis optica: concepts in evolution

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3373605

Quantification and functional characterization of antibodies to native aquaporin 4 in neuromyelitis optica

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3373605

IFNβ-1b may severely exacerbate Japanese optic-spinal MS in neuromyelitis optica spectrum

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3373605

AQP4 antibodies in neuromyelitis optica: diagnostic and pathogenetic relevance

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3373605

Standardized method for the detection of antibodies to aquaporin-4 based on a highly sensitive immunofluorescence assay employing recombinant target antigen

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3373605

Antibody to aquaporin-4 in the long-term course of neuromyelitis optica

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3373605

Spectrum of pediatric neuromyelitis optica

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3373605

Treatment of neuromyelitis optica with rituximab: retrospective analysis of 25 patients

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3373605

Aquaporin-4 antibodies in neuromyelitis optica and longitudinally extensive transverse myelitis

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3373605

Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3373605

Revised diagnostic criteria for neuromyelitis optica

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3373605

Measurement of observer agreement

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3373605

The clinical course of neuromyelitis optica (Devic's syndrome).

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3373605

Frequency and prognostic impact of antibodies to aquaporin-4 in patients with optic neuritis

3 June 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0038896

Frequency and syndrome specificity of antibodies to aquaporin-4 in neurological patients with rheumatic disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0038896

Statistical discrimination in the presence of selection effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0038896

NMO-IgG predicts the outcome of recurrent optic neuritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0038896

Failure of natalizumab to prevent relapses in neuromyelitis optica.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0038896

Massive astrocyte destruction in neuromyelitis optica despite natalizumab therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0038896

Repeated treatment with rituximab based on the assessment of peripheral circulating memory B cells in patients with relapsing neuromyelitis optica over 2 years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0038896

An open label study of the effects of rituximab in neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0038896

NMO-IgG in the diagnosis of neuromyelitis optica.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0038896

Antiacquaporin 4 antibodies detection by different techniques in neuromyelitis optica patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0038896

NMO-IgG and Devic's neuromyelitis optica: a French experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0038896

Neuromyelitis optica and anti-aquaporin-4 antibodies measured by an enzyme-linked immunosorbent assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0038896

Development of extensive brain lesions following fingolimod (FTY720) treatment in a patient with neuromyelitis optica spectrum disorder.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3373605

Interferon Beta treatment in neuromyelitis optica: increase in relapses and aquaporin 4 antibody titers

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3373605

Diagnosis of neuromyelitis spectrum disorders: comparative sensitivities and specificities of immunohistochemical and immunoprecipitation assays.

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3373605

Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis

27 November 2018

1 reference

12 December 2020

Neuromyelitis optica and non organ-specific autoimmunity

1 reference

12 December 2020

Neuromyelitis optica-IgG in childhood inflammatory demyelinating CNS disorders

1 reference

12 December 2020

Quantitative measurement of anti-aquaporin-4 antibodies by enzyme-linked immunosorbent assay using purified recombinant human aquaporin-4

1 reference

12 December 2020

Western blot analysis for the detection of serum antibodies recognizing linear Aquaporin-4 epitopes in patients with Neuromyelitis Optica

1 reference

12 December 2020

Neuromyelitis optica-IgG (aquaporin-4) autoantibodies in immune mediated optic neuritis

1 reference

12 December 2020

Autoantibodies against aquaporin-4 in patients with neuropsychiatric systemic lupus erythematosus and primary Sjögren's syndrome

1 reference

12 December 2020

Strategy for anti-aquaporin-4 auto-antibody identification and quantification using a new cell-based assay

1 reference

12 December 2020

Impact of rituximab on relapse rate and disability in neuromyelitis optica

1 reference

12 December 2020